OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Lawrence Honig

2 Projects | 1 Researchers | $250,000 Invested

2011

Trustees of Columbia University in the City of New York

Lawrence Honig, MD, PhD

Magnetic Resonance Spectroscopy (MRS) to assess progression of Alzheimer Disease (AD)

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Neuronal Degeneration
  • Status: Closed

2010

Trustees of Columbia University in the City of New York

Lawrence Honig, MD, PhD

Combined CSF biomarkers and GBA genotype for diagnosis of LBD

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: zzAbeta
  • Status: Closed